Stępnik, M <br/><br/>
Assessment of the involvement of oxidative stress and Mitogen-Activated Protein Kinase signaling pathways in the cytotoxic effects of arsenic trioxide and its combination with sulindac or its metabolites: sulindac sulfide and sulindac sulfone on human leukemic cell lines.  [electronic resource] 

 -  Medical oncology (Northwood, London, England)  Jun 2012 
 - 1161-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1559-131X 
<br/><br/><label>Standard No.: </label>10.1007/s12032-011-9920-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Arsenic Trioxide<br/>Arsenicals--administration & dosage<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Drug Synergism<br/>Glutathione--metabolism<br/>Humans<br/>Leukemia--drug therapy<br/>Mitogen-Activated Protein Kinases--metabolism<br/>Oxidative Stress--drug effects<br/>Oxides--administration & dosage<br/>Reactive Oxygen Species--metabolism<br/>Signal Transduction--drug effects<br/>Sulindac--administration & dosage